Symphogen
Develops antibodies for cancer treatments
Symphogen has raised €282M across 6 funding rounds from 5 investors, most recently a Debt round in Oct 2015. Based in Ballerup, Denmark; founded 2000; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€282M
€282,319,684
Funding rounds
6
Investors
5
distinct backers
Active since
2004-11
latest 2015-10
Funding by year
EUR raised per yearSymphogen — funding by year — interactive chart.
Data table
| Symphogen — funding by year | |
|---|---|
| 2004 | €20M |
| 2005 | €21M |
| 2009 | €33M |
| 2011 | €100M |
| 2013 | €41M |
| 2015 | €68M |
Signals
High confidenceRaise-next likelihood9
base rate 45% for Debt
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6 rounds raised
- ▼ Old (26y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
6 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-10-01 | Debt | €68M | Novo A,S | View deal → |
| 2013-05-01 | Growth/Late | €41M | Novo A,S | View deal → |
| 2011-02-01 | Series D+ | €100M | Essex Woodlands Health Ventures,Novo A,S | View deal → |
| 2009-02-01 | Growth/Late | €33M | Essex Woodlands Health Ventures | View deal → |
| 2006-01-01 | Series D+ | €21M | Essex Woodlands Health Ventures,Gilde Healthcare,Novo A,S,Takeda Ventures | View deal → |
| 2004-11-01 | Series C | €20M | Essex Woodlands Health Ventures,Novo A,S | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData